The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies
Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal. MEDLINE, the Index of Portuguese Medical Journals and SIBUL...
Gespeichert in:
| Veröffentlicht in: | Revista portuguesa de cardiologia 2014-09, Vol.33 (9), p.555-560 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng ; por |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 560 |
|---|---|
| container_issue | 9 |
| container_start_page | 555 |
| container_title | Revista portuguesa de cardiologia |
| container_volume | 33 |
| creator | Caldeira, Daniel Barra, Márcio David, Cláudio Costa, João Ferreira, Joaquim J Pinto, Fausto J |
| description | Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal.
MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched for Portuguese observational studies reporting the proportion of anticoagulated patients with AF. The pooled estimated prevalence of anticoagulated patients and respective 95% confidence interval (CI) were determined by means of a meta-analysis.
Seven studies were included for analysis, of which four were conducted in a hospital environment and three in the general community. These studies enrolled a total of 891 patients with AF. The pooled estimated prevalence of anticoagulated patients was 40% (95% CI: 32-48%).
The prevalence of OAC in Portuguese AF patients is low. There is a need to promote change in OAC prescribing habits for AF patients in Portugal, in accordance with international guidelines. |
| doi_str_mv | 10.1016/j.repc.2014.02.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1634500933</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1634500933</sourcerecordid><originalsourceid>FETCH-LOGICAL-p167t-9ee1e34f8c3aae127f7f215273ca3ed9fcce373c2775848f5ed9ae69ebe6ccb63</originalsourceid><addsrcrecordid>eNpFkEtLw0AQxxdBbKn9Ah5kj14S95FsGm9SfEFBwXoOk82k3ZKXu5tKP4jf16VWnMu8_vMbZgi54izmjKvbXWxx0LFgPImZiIM7I1PBsyQSTLIJmTu3Y8EU47lUF2QiUpGwheJT8r3eIh0s7qHBTiPta9pbaCh03ugeNmMD3vQdNR0dQoSdd_TL-C0Fb03Q1aa0pvkXvfXWjxto7uj7wXlsQ0PTgDf4FZgVbdFDBB00B2fccVvp0O6P8wHn_FgZdJfkvIbG4fzkZ-Tj8WG9fI5Wr08vy_tVNHCV-ShH5CiTeqElAHKR1VkteCoyqUFilddaowyJyLJ0kSzqNNQAVY4lKq1LJWfk5pc72P5zROeL1jiN4Z4O-9EVXMkkZSyXMkivT9KxbLEqBmtasIfi75XyB58ieq0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1634500933</pqid></control><display><type>article</type><title>The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Caldeira, Daniel ; Barra, Márcio ; David, Cláudio ; Costa, João ; Ferreira, Joaquim J ; Pinto, Fausto J</creator><creatorcontrib>Caldeira, Daniel ; Barra, Márcio ; David, Cláudio ; Costa, João ; Ferreira, Joaquim J ; Pinto, Fausto J</creatorcontrib><description>Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal.
MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched for Portuguese observational studies reporting the proportion of anticoagulated patients with AF. The pooled estimated prevalence of anticoagulated patients and respective 95% confidence interval (CI) were determined by means of a meta-analysis.
Seven studies were included for analysis, of which four were conducted in a hospital environment and three in the general community. These studies enrolled a total of 891 patients with AF. The pooled estimated prevalence of anticoagulated patients was 40% (95% CI: 32-48%).
The prevalence of OAC in Portuguese AF patients is low. There is a need to promote change in OAC prescribing habits for AF patients in Portugal, in accordance with international guidelines.</description><identifier>EISSN: 2174-2030</identifier><identifier>DOI: 10.1016/j.repc.2014.02.014</identifier><identifier>PMID: 25240861</identifier><language>eng ; por</language><publisher>Portugal</publisher><subject>Administration, Oral ; Anticoagulants - administration & dosage ; Anticoagulants - therapeutic use ; Atrial Fibrillation - complications ; Humans ; Portugal ; Thromboembolism - prevention & control</subject><ispartof>Revista portuguesa de cardiologia, 2014-09, Vol.33 (9), p.555-560</ispartof><rights>Copyright © 2014 Sociedade Portuguesa de Cardiologia. Published by Elsevier España. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,862,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25240861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Caldeira, Daniel</creatorcontrib><creatorcontrib>Barra, Márcio</creatorcontrib><creatorcontrib>David, Cláudio</creatorcontrib><creatorcontrib>Costa, João</creatorcontrib><creatorcontrib>Ferreira, Joaquim J</creatorcontrib><creatorcontrib>Pinto, Fausto J</creatorcontrib><title>The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies</title><title>Revista portuguesa de cardiologia</title><addtitle>Rev Port Cardiol</addtitle><description>Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal.
MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched for Portuguese observational studies reporting the proportion of anticoagulated patients with AF. The pooled estimated prevalence of anticoagulated patients and respective 95% confidence interval (CI) were determined by means of a meta-analysis.
Seven studies were included for analysis, of which four were conducted in a hospital environment and three in the general community. These studies enrolled a total of 891 patients with AF. The pooled estimated prevalence of anticoagulated patients was 40% (95% CI: 32-48%).
The prevalence of OAC in Portuguese AF patients is low. There is a need to promote change in OAC prescribing habits for AF patients in Portugal, in accordance with international guidelines.</description><subject>Administration, Oral</subject><subject>Anticoagulants - administration & dosage</subject><subject>Anticoagulants - therapeutic use</subject><subject>Atrial Fibrillation - complications</subject><subject>Humans</subject><subject>Portugal</subject><subject>Thromboembolism - prevention & control</subject><issn>2174-2030</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtLw0AQxxdBbKn9Ah5kj14S95FsGm9SfEFBwXoOk82k3ZKXu5tKP4jf16VWnMu8_vMbZgi54izmjKvbXWxx0LFgPImZiIM7I1PBsyQSTLIJmTu3Y8EU47lUF2QiUpGwheJT8r3eIh0s7qHBTiPta9pbaCh03ugeNmMD3vQdNR0dQoSdd_TL-C0Fb03Q1aa0pvkXvfXWjxto7uj7wXlsQ0PTgDf4FZgVbdFDBB00B2fccVvp0O6P8wHn_FgZdJfkvIbG4fzkZ-Tj8WG9fI5Wr08vy_tVNHCV-ShH5CiTeqElAHKR1VkteCoyqUFilddaowyJyLJ0kSzqNNQAVY4lKq1LJWfk5pc72P5zROeL1jiN4Z4O-9EVXMkkZSyXMkivT9KxbLEqBmtasIfi75XyB58ieq0</recordid><startdate>201409</startdate><enddate>201409</enddate><creator>Caldeira, Daniel</creator><creator>Barra, Márcio</creator><creator>David, Cláudio</creator><creator>Costa, João</creator><creator>Ferreira, Joaquim J</creator><creator>Pinto, Fausto J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201409</creationdate><title>The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies</title><author>Caldeira, Daniel ; Barra, Márcio ; David, Cláudio ; Costa, João ; Ferreira, Joaquim J ; Pinto, Fausto J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p167t-9ee1e34f8c3aae127f7f215273ca3ed9fcce373c2775848f5ed9ae69ebe6ccb63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; por</language><creationdate>2014</creationdate><topic>Administration, Oral</topic><topic>Anticoagulants - administration & dosage</topic><topic>Anticoagulants - therapeutic use</topic><topic>Atrial Fibrillation - complications</topic><topic>Humans</topic><topic>Portugal</topic><topic>Thromboembolism - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Caldeira, Daniel</creatorcontrib><creatorcontrib>Barra, Márcio</creatorcontrib><creatorcontrib>David, Cláudio</creatorcontrib><creatorcontrib>Costa, João</creatorcontrib><creatorcontrib>Ferreira, Joaquim J</creatorcontrib><creatorcontrib>Pinto, Fausto J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Revista portuguesa de cardiologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Caldeira, Daniel</au><au>Barra, Márcio</au><au>David, Cláudio</au><au>Costa, João</au><au>Ferreira, Joaquim J</au><au>Pinto, Fausto J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies</atitle><jtitle>Revista portuguesa de cardiologia</jtitle><addtitle>Rev Port Cardiol</addtitle><date>2014-09</date><risdate>2014</risdate><volume>33</volume><issue>9</issue><spage>555</spage><epage>560</epage><pages>555-560</pages><eissn>2174-2030</eissn><abstract>Oral anticoagulation (OAC) is an effective treatment in the prevention of thromboembolic events in patients with atrial fibrillation (AF). The aim of this review was to estimate the prevalence of OAC therapy in patients with AF in Portugal.
MEDLINE, the Index of Portuguese Medical Journals and SIBUL (the Bibliographic Catalog of the Integrated Library System of the University of Lisbon) were searched for Portuguese observational studies reporting the proportion of anticoagulated patients with AF. The pooled estimated prevalence of anticoagulated patients and respective 95% confidence interval (CI) were determined by means of a meta-analysis.
Seven studies were included for analysis, of which four were conducted in a hospital environment and three in the general community. These studies enrolled a total of 891 patients with AF. The pooled estimated prevalence of anticoagulated patients was 40% (95% CI: 32-48%).
The prevalence of OAC in Portuguese AF patients is low. There is a need to promote change in OAC prescribing habits for AF patients in Portugal, in accordance with international guidelines.</abstract><cop>Portugal</cop><pmid>25240861</pmid><doi>10.1016/j.repc.2014.02.014</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | EISSN: 2174-2030 |
| ispartof | Revista portuguesa de cardiologia, 2014-09, Vol.33 (9), p.555-560 |
| issn | 2174-2030 |
| language | eng ; por |
| recordid | cdi_proquest_miscellaneous_1634500933 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Administration, Oral Anticoagulants - administration & dosage Anticoagulants - therapeutic use Atrial Fibrillation - complications Humans Portugal Thromboembolism - prevention & control |
| title | The prevalence of oral anticoagulation in patients with atrial fibrillation in Portugal: Systematic review and meta-analysis of observational studies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T02%3A28%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prevalence%20of%20oral%20anticoagulation%20in%20patients%20with%20atrial%20fibrillation%20in%20Portugal:%20Systematic%20review%20and%20meta-analysis%20of%20observational%20studies&rft.jtitle=Revista%20portuguesa%20de%20cardiologia&rft.au=Caldeira,%20Daniel&rft.date=2014-09&rft.volume=33&rft.issue=9&rft.spage=555&rft.epage=560&rft.pages=555-560&rft.eissn=2174-2030&rft_id=info:doi/10.1016/j.repc.2014.02.014&rft_dat=%3Cproquest_pubme%3E1634500933%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1634500933&rft_id=info:pmid/25240861&rfr_iscdi=true |